Phase II Multicenter Study of the Epidermal Growth Factor Receptor Antibody Cetuximab and Cisplatin for Recurrent and Refractory Squamous Cell Carcinoma of the Head and Neck

2006 ◽  
Vol 2006 ◽  
pp. 258-260
Author(s):  
N.H. Hanna
Sign in / Sign up

Export Citation Format

Share Document